Rani Therapeutics Holdings (RANI) DMA 200 (2022 - 2026)

Rani Therapeutics Holdings (RANI) DMA 200 (2022 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	DMA 200
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	3.91
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	135.66
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	8.31
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	25.75
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	16.68
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	4.44
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	9.87
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	437.65
9	Abivax	95.45 Bn	95.45 Bn	-	110.33
10	Rani Therapeutics Holdings	144.82 Mn	151.96 Mn	-	1.16

Download Data